Medicon Valley Alliance are pleased to invite you to an exclusive Good Morning Meeting hosted by Theradex Oncology and Simsen Diagnostics on the 18th of November 2025. Designed specifically for pharmaceutical companies developing cancer therapies, this gathering offers an opportunity to gain actionable insights and explore innovative solutions for oncology clinical trials. Sharing the latest strategies for designing effective oncology studies, as well as actionable approaches for incorporating personalised, tumour-informed ctDNA analysis to enhance patient selection, monitoring, and trial outcomes, this event will equip you with practical knowledge to drive success in your oncology studies.
For more information and to Register: Invitation to MVA Good Morning Meeting with Theradex and Simsen Diagnostic